Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T19:02:44.838Z.
Consensus retrieved: 2026-10-06T14:22:48.829Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T19:02:44.838Z.
Quote observation: 2026-10-06T18:59:55.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b626f321e8bf7fc1aa576344fb562ad2ba7a1b85fa36d8388ebfe6a76482c652
Forward PE Ratio (N/A) = Dated Quote Price ($0.10) / Consensus Forward EPS ($42.66)
FORWARD PE RATIO
N/A
NewGenIvf Group Limited
Market Cap
$6001.00
Forward PE Ratio
N/A
Market Cap
$30263.00
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| NewGenIvf Group Limited (NIVF) | $6001.00 | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30263.00 | N/A |
| Zhongchao Inc. (ZCMD)vs › | $31083.00 | N/A |
| Akanda Corp. (AKAN)vs › | $61819.00 | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $70876.00 | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $96215.00 | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $108771.00 | N/A |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $357350.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $0.10, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $42.66 | $42.66 – $42.66 | 1 | 0.0x |
| 2027-12-31 | $84.06 | $84.06 – $84.06 | 1 | 0.0x |
| 2028-12-31 | $132.30 | $132.30 – $132.30 | 1 | 0.0x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
